Povidone-iodine (PVP-I) is a trusted antiseptic, frequently used for its potent antimicrobial properties. For children aged two years and older, it aids first aid wound care by reducing infection risks in minor cuts and abrasions.1 Pharmacists play a key role in educating caregivers about its proper use.
MECHANISM OF ACTION AND CLINICAL APPLICATIONS
PVP-I’s antimicrobial action stems from the release of free iodine, which disrupts microbial proteins and nucleic acids. This broad-spectrum activity encompasses bacteria, fungi, viruses, and protozoa. In first aid, PVP-I is used primarily as a 5% solution to treat minor injuries, making it a valuable tool for preventing infections.2
Beyond basic wound care, PVP-I has demonstrated efficacy in specialised childhood applications. For instance, research on early childhood caries (ECC) highlighted its role in delaying bacterial regrowth. Children treated with quarterly applications of 10% PVP-I following dental rehabilitation experienced significant reductions in Streptococcus mutans levels and no new or recurring caries over a one-year period.3
Another critical application emerged during the Covid-19 pandemic. Low-concentration PVP-I solutions (0.23–1%) demonstrated rapid inactivation of SARS-CoV-2 in vitro within 15-30 seconds. 4
SAFETY AND ADVERSE EFFECTS
PVP-I is considered safe when used according to recommended guidelines. Its application should be restricted to intact skin to mitigate risks of systemic iodine absorption.1 Avoidance on large areas or prolonged use minimises the potential for rare incidents like thyroid dysfunction.4 For typical first aid purposes, such risks are negligible.
However, rare adverse effects underscore the need for caution and the importance of monitoring for signs of hypersensitivity, especially in children with potential iodine allergies.
PVP-I VERSUS OTHER ANTISEPTICS
Pharmacists may encounter caregivers opting for alternatives like chlorhexidine, which has a lower risk of skin irritation and systemic absorption issues. However, chlorhexidine’s narrower antimicrobial spectrum makes it less effective against fungi and viruses. PVP-I’s broad efficacy, particularly in cases with viral or fungal risks, reinforces its role as a versatile first aid antiseptic.4
PHARMACISTS’ ROLE IN BEST PRACTICES
Pharmacists are pivotal in ensuring PVP-I’s safe and effective application. Recommendations for caregivers should include:
• Preparation: Clean the wound thoroughly to remove dirt and contaminants.1
• Application: Use a small amount of PVP-I as per the dosing instructions, allowing it to dry before covering with a sterile bandage.1
• Precautions: Avoid use on mucosal surfaces, animal bites, or deep puncture wounds.1
• Monitoring: Discontinue use if irritation, redness, or other adverse signs occur, and refer the child for medical attention if symptoms persist.1
Pharmacists can also educate caregivers on proper storage and label warnings, emphasising that PVP-I is intended for short-term use only. Caregiver awareness of allergies and hypersensitivity risks helps mitigate adverse outcomes.
PVP-I remains integral to wound care in children aged two and older, offering broad-spectrum antimicrobial properties with a good safety profile.1 By equipping caregivers with clear guidance, pharmacists ensure PVP-I is used to its full potential while safeguarding children’s health outcomes.
REFERENCES
- Target Corporation. Povidone-Iodine 10% Solution, First Aid Antiseptic Drug Info. DailyMed. May 2024. Accessed October 2025. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78693ec1-d725-408c-bb95-2261faad84ac
- Mundipharma (Pty) Ltd. Betadine First Aid Cream 5% (w/w) Povidone-Iodine Product Information. Cape Town, South Africa: Mundipharma (Pty) Ltd. September 2022. Accessed October 2025.
- Simratvir M, Singh N, Chopra S, et al. Efficacy of 10% Povidone Iodine in Children Affected with Early Childhood Caries: An In Vivo Study. J Clin Pediatr Dent. 2010. Accessed October 2025. Available from: https://www.jocpd.com/articles/10.17796/jcpd.34.3.l552816527xtv122.
- Chorney SR, Rizzi MD, Dedhia K. Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic. Am J Otolaryngol. Nov-Dec 2020. Accessed October 2025. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7501061/.
Images supplied by: Getty Images



